PYC Therapeutics Limited (ASX:PYC)
Australia
· Delayed Price · Currency is AUD 1.500
+0.020 (1.35%)
Mar 10, 2026, 11:09 AM AEST
PYC Therapeutics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 120.69 | 153.05 | 66.87 | 15.57 | 29.11 | 18.44 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 33.07 | Upgrade
|
| Cash & Short-Term Investments | 120.69 | 153.05 | 66.87 | 15.57 | 29.11 | 51.5 | Upgrade
|
| Cash Growth | 145.04% | 128.86% | 329.47% | -46.51% | -43.48% | 102.54% | Upgrade
|
| Accounts Receivable | 32.59 | - | - | - | - | - | Upgrade
|
| Other Receivables | - | 24.07 | 18 | 16.25 | 10.07 | 0.19 | Upgrade
|
| Receivables | 32.59 | 24.07 | 18 | 16.25 | 10.07 | 0.19 | Upgrade
|
| Other Current Assets | 0.46 | 0.41 | 0.74 | 0.05 | 0.07 | 0.09 | Upgrade
|
| Total Current Assets | 153.74 | 177.53 | 85.61 | 31.87 | 39.25 | 51.78 | Upgrade
|
| Property, Plant & Equipment | 1.64 | 1.9 | 1.57 | 1.04 | 1.63 | 1.49 | Upgrade
|
| Other Intangible Assets | 3.75 | 3.85 | 4.05 | 4.25 | 4.45 | 4.65 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | 0.02 | 0.02 | Upgrade
|
| Total Assets | 159.13 | 183.28 | 91.24 | 37.17 | 45.35 | 57.94 | Upgrade
|
| Accounts Payable | 9.56 | 8.75 | 7.53 | 4.92 | 2.57 | 2.35 | Upgrade
|
| Accrued Expenses | 1.07 | 2.65 | 1.26 | 3.15 | 1.38 | 0.61 | Upgrade
|
| Current Portion of Leases | 0.39 | 0.4 | 0.31 | 0.18 | 0.26 | 0.19 | Upgrade
|
| Other Current Liabilities | - | 0.52 | 0.01 | 0.15 | 0.17 | 0.16 | Upgrade
|
| Total Current Liabilities | 11.01 | 12.32 | 9.11 | 8.41 | 4.39 | 3.3 | Upgrade
|
| Long-Term Leases | 0.44 | 0.62 | 0.8 | 0.14 | 0.68 | 0.54 | Upgrade
|
| Pension & Post-Retirement Benefits | 0.35 | 0.33 | 0.27 | 0.18 | 0.08 | 0.18 | Upgrade
|
| Total Liabilities | 11.8 | 13.27 | 10.18 | 8.72 | 5.15 | 4.02 | Upgrade
|
| Common Stock | 369.59 | 369.59 | 230.58 | 140.09 | 125.99 | 125.99 | Upgrade
|
| Retained Earnings | -229.03 | -206.2 | -155.89 | -118.17 | -95.38 | -81.52 | Upgrade
|
| Comprehensive Income & Other | 6.62 | 6.18 | 5.81 | 5.83 | 8.74 | 8.57 | Upgrade
|
| Total Common Equity | 147.18 | 169.57 | 80.5 | 27.75 | 39.35 | 53.04 | Upgrade
|
| Minority Interest | 0.14 | 0.43 | 0.56 | 0.69 | 0.85 | 0.88 | Upgrade
|
| Shareholders' Equity | 147.33 | 170.01 | 81.05 | 28.44 | 40.2 | 53.92 | Upgrade
|
| Total Liabilities & Equity | 159.13 | 183.28 | 91.24 | 37.17 | 45.35 | 57.94 | Upgrade
|
| Total Debt | 0.83 | 1.02 | 1.11 | 0.32 | 0.94 | 0.73 | Upgrade
|
| Net Cash (Debt) | 119.86 | 152.03 | 65.76 | 15.26 | 28.17 | 50.77 | Upgrade
|
| Net Cash Growth | 149.49% | 131.18% | 331.05% | -45.84% | -44.52% | 106.14% | Upgrade
|
| Net Cash Per Share | 0.21 | 0.30 | 0.17 | 0.05 | 0.09 | 0.16 | Upgrade
|
| Filing Date Shares Outstanding | 583.26 | 583.26 | 466.61 | 373.29 | 318.09 | 318.09 | Upgrade
|
| Total Common Shares Outstanding | 583.26 | 583.26 | 466.61 | 341.65 | 318.09 | 318.09 | Upgrade
|
| Working Capital | 142.73 | 165.21 | 76.51 | 23.47 | 34.86 | 48.48 | Upgrade
|
| Book Value Per Share | 0.25 | 0.29 | 0.17 | 0.08 | 0.12 | 0.17 | Upgrade
|
| Tangible Book Value | 143.43 | 165.72 | 76.45 | 23.5 | 34.9 | 48.39 | Upgrade
|
| Tangible Book Value Per Share | 0.25 | 0.28 | 0.16 | 0.07 | 0.11 | 0.15 | Upgrade
|
| Machinery | - | 4.53 | 3.55 | 3.24 | 2.81 | 2.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.